ESMO Immuno Oncology Congress Geneva – December 7-10
OncoArendi will present a poster on Friday 8th at 12:30 titled: Novel Dual Arginase 1/2 Inhibitor OATD-02 Improves Efficacy of Immune Checkpoint Inhibitors (ESMO Immuno Oncology 2017).
OncoArendi will present a poster on Friday 8th at 12:30 titled: Novel Dual Arginase 1/2 Inhibitor OATD-02 Improves Efficacy of Immune Checkpoint Inhibitors (ESMO Immuno Oncology 2017).